Evidence map›Paper›PMID 41960340›Full record

ArticleResearch square2026

Post-matching analysis after coarsened exact matching: implications of coarsening for residual confounding and model dependence.

Fei Wan

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Fei WanDivision of Public Health Sciences, Department of Surgery, Washington University School of Medicine.

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
NCI NIH HHS P30 CA091842
6 · The paper itself

Abstract

Background: Coarsened Exact Matching (CEM) is a widely used design strategy aimed at reducing confounding in observational studies by matching treated and control units within strata of coarsened covariates. It is often promoted as a method that mimics a randomized block design, which has led many researchers to apply simple, unadjusted statistical methods-such as paired Methods: We examine the implications of this coarsening process for post-matching analysis using literature review, conceptual arguments, and simulation studies. In particular, we evaluate how within-stratum heterogeneity in the original covariates affects residual confounding and the dependence of treatment effect estimates on outcome model specification. Results: Our results show that matching on coarsened covariates can leave systematic differences between treated and control subjects within matched strata. These differences introduce residual confounding that does not disappear with increasing sample size. Simulation results further demonstrate a bias-variance trade-off induced by coarsening: fine coarsening may reduce residual confounding but can result in substantial data loss, whereas coarse binning preserves sample size at the cost of increased bias and greater reliance on outcome model specification. Conclusions: CEM should be regarded primarily as a preprocessing tool for improving covariate overlap rather than as a stand-alone solution for confounding control. Valid causal inference following CEM generally requires regression adjustment using the original, uncoarsened covariates, and unadjusted analyses of matched data may yield biased treatment effect estimates.

Indexed as

BiasCoarsened exact matchingCurse of dimensionalityModel dependencePropensity score matchingResidual confounding

Identifiers

PMID41960340
PMCPMC13060533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.